Good Life Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-322
| Closed | -$204K | – | 529 |
|
|
2025
Q1 | $204K | Buy |
322
+18
| +6% | +$11.4K | 0.01% | 467 |
|
|
2024
Q4 | $217K | Sell |
304
-80
| -21% | -$57K | 0.02% | 442 |
|
|
2024
Q3 | $404K | Buy |
384
+144
| +60% | +$151K | 0.02% | 394 |
|
|
2024
Q2 | $252K | Buy |
240
+6
| +3% | +$6.31K | 0.02% | 390 |
|
|
2024
Q1 | $225K | Hold |
234
| – | – | 0.02% | 402 |
|
|
2023
Q4 | $206K | Buy |
+234
| New | +$206K | 0.02% | 405 |
|
|
2022
Q2 | – | Sell |
-3,288
| Closed | -$2.3M | – | 387 |
|
|
2022
Q1 | $2.3M | Buy |
3,288
+142
| +5% | +$99.2K | 0.29% | 69 |
|
|
2021
Q4 | $1.99M | Buy |
3,146
+87
| +3% | +$54.9K | 0.24% | 78 |
|
|
2021
Q3 | $1.85M | Buy |
+3,059
| New | +$1.85M | 0.25% | 81 |
|